Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: Week 48 Efficacy Outcomes by Baseline Demographics in the Phase 2/3 PHOTON Trial

被引：0
作者：
Ghorayeb, Ghassan [1 ]
机构：
[1] West Virginia Univ, Eye Inst, Morgantown, WV USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2707
引用
收藏
页数：2
相关论文
共 50 条
[21]   Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial [J].
Lanzetta, Paolo ;
Korobelnik, Jean-Francois ;
Heier, Jeffrey S. ;
Leal, Sergio ;
Holz, Frank G. ;
Clark, W. Lloyd ;
Eichenbaum, David ;
Iida, Tomohiro ;
Xiaodong, Sun ;
Berliner, Alyson J. ;
Schulze, Andrea ;
Schmelter, Thomas ;
Schmidt-Ott, Ursula ;
Zhang, Xin ;
Vitti, Robert ;
Chu, Karen W. ;
Reed, Kimberly ;
Rao, Rohini ;
Bhore, Rafia ;
Cheng, Yenchieh ;
Sun, Wei ;
Hirshberg, Boaz ;
Yancopoulos, George ;
Wong, Tien Y. .
LANCET, 2024, 403 (10432) :1141-1152
[22]   Tolerability and safety of intravitreal aflibercept 8 mg in the Phase 3 PULSAR trial of patients with neovascular age-related macular degeneration [J].
Korobelnik, Jean-Francois ;
Schmidt-Ott, Ursula Maria ;
Schulze, Andrea ;
Zhang, Xin ;
Leal, Sergio .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
[23]   Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: ROTATED Trial 52 Week Results [J].
Taylor, Caitlen ;
Frazier, Heather ;
Rex, Priscila ;
Marcus, William ;
Starnes, Davis ;
Walia, Harveen ;
Singh, Harinderjit ;
Lalane, Robert ;
Marcus, Dennis M. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
[24]   Costs of novel 8 mg aflibercept and faricimab compared to 2mg aflibercept and bevacizumab for neovascular age-related macular degeneration and diabetic macular edema at 2 years [J].
Sood, Shefali ;
Vail, Daniel ;
Berkowitz, Sean ;
Zhang, Casey ;
Coovadia, Zaheer ;
Budhu, Uma ;
Friedman, Scott ;
Parikh, Ravi .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
[25]   Intravitreal Aflibercept 8mg Injection in patients with neovascular age-related macular degeneration: 60+96 week results from the Phase 3 Pulsar trial [J].
Chang, Andrew .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (09) :933-933
[26]   BETTER BASELINE VISION LEADS TO BETTER OUTCOMES AFTER THE 0.19-mg FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT IN DIABETIC MACULAR EDEMA [J].
Gonzalez, Victor ;
Luo, Caesar ;
Almeida, David R. p. ;
Cutino, Antonio ;
Coughlin, Brandon ;
Kasper, Jonathan F. ;
Kiernan, Daniel ;
PALADIN Study Grp .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2023, 43 (08) :1301-1307
[27]   Aflibercept 8 mg in patients with neovascular age- related macular degeneration: Phase 3 PULSAR trial 96-week results [J].
Chang, Andrew .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2025, 53
[28]   EFFICACY OF 1.25 MG VERSUS 2.5 MG INTRAVITREAL BEVACIZUMAB FOR DIABETIC MACULAR EDEMA Six-Month Results of a Randomized Controlled Trial [J].
Lam, Dennis S. C. ;
Lai, Timothy Y. Y. ;
Lee, Vincent Y. W. ;
Chan, Carmen K. M. ;
Liu, David T. L. ;
Mohamed, Shaheeda ;
Li, Chi-Lai .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (03) :292-299
[29]   RELATIVE EFFECTIVENESS OF FARICIMAB VS AFLIBERCEPT 8 MG AFTER LOADING PHASE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA [J].
Buhrer, C. ;
Tabano, D. ;
Cox, O. .
VALUE IN HEALTH, 2023, 26 (12) :S47-S47
[30]   Systematic Review of Safety Across the Phase 2 and 3 Clinical Trials of Intravitreal Aflibercept Injection in Neovascular Age-Related Macular Degeneration, Macular Edema Following Retinal Vein Occlusion, and Diabetic Macular Edema [J].
Kitchens, John William .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
12345